Delphia Therapeutics
Delphia is pioneering activation lethality - a next-generation precision medicine approach that targets cancer's surprising vulnerability to oncogene overactivation.
HQ location
Cambridge, United States
Website
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.